BLOG

Monday, November 25, 2019

Dr Reddy's Labs extends gains for second straight day, hits 33-month high

Analysts at SBICAP Securities upgraded the stock with 'buy' rating and target price of Rs 3,200 per share

from Home Page https://ift.tt/2OLidkf
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...